TAG:
managed care
New BlueCard Policies Affect Lab Test Claims
By Joseph Burns | From the Volume XIX No. 10 – July 16, 2012 Issue
CEO SUMMARY: This new policy from the Blue Cross and Blue Shield Association (BCBSA) becomes effective on October 14, 2012. No longer can a local lab provide service to a member under the BlueCard program and be paid by the local plan in the region where the service was provided….
Indiana Clinical Lab Taps Data to Improve Service to Doctors
By Joseph Burns | From the Volume XIX No. 9 – June 25, 2012 Issue
CEO SUMMARY: Business intelligence is on the verge of becoming the next “big thing” in clinical laboratory management. Lab teams are using real-time data dashboards to quickly identify problems and take proactive steps to raise service levels to clients. South Bend Medical Foundation …
Health Insurers Now Finding Ways to Cut Costs and Shed Risks
By Robert Michel | From the Volume XIX No. 8 – June 4, 2012 Issue
CEO SUMMARY: Both employers and health insurers are taking aggressive steps to rein in healthcare costs. Several strategies to control spending and create powerful new incentives for providers are gaining favor. At this year’s Executive War College, Paul Mango of McKinsey & Company,…
Top 10 IT Trends Send Message For Labs & Pathology Groups
By Robert Michel | From the Volume XIX No. 6 – April 23, 2012 Issue
CEO SUMMARY: Healthcare’s shift away from fee-for-service medicine and toward integrated clinical care is widely recognized. However, few lab administrators and pathologists are aware of the even faster transformation underway in healthcare informatics. Presented here are the “Top 10 …
Lab Strategies for Population Health Management
By R. Lewis Dark | From the Volume XIX No. 6 – April 23, 2012 Issue
EXTRAORDINARY THINGS ARE HAPPENING WITHIN THE HEALTH SYSTEM of this country. Powerful forces of change and transformation are at work in ways that have yet to be fully understood. The only certainty about the healthcare system we know today is that it will look very different in the next five years….
Payer Trend in New Hampshire Is to Engage Lab Patients
By Robert Michel | From the Volume XIX No. 5 – April 2, 2012 Issue
CEO SUMMARY: A health insurer’s two-year-old effort to have patients choose low-cost laboratory testing options is causing patients to shift their lab work away from New Hampshire’s hospitals and instead use Quest Diagnostics, LabCorp, and ConVerge (a commercial lab company). This new…
Hospital Labs Feel More Pressure to Lower Prices
By Robert Michel | From the Volume XIX No. 5 – April 2, 2012 Issue
CEO SUMMARY: It’s a new trend and gathering momentum. At managed care contract renewal time, more hospitals and health systems report much stronger pressure from health insurers to accept deep cuts to laboratory test prices. At the same time, managed care companies are getting smarter a…
Quest Diagnostics and LabCorp Report Q-4, Full Year Earnings
By Robert Michel | From the Volume XIX No. 4 – March 12, 2012 Issue
IN RECENT WEEKS, each of the nation’s two largest public laboratory companies reported earnings for fourth quarter 2011 and full year 2011. Organic growth at both lab companies continues at low single-digit rates. This continues the pattern of relatively modest growth that has been posted by each …
Today’s Lab Test Model Won’t Survive Reforms
By Robert Michel | From the Volume XIX No. 4 – March 12, 2012 Issue
CEO SUMMARY: For more than three decades, independent lab companies have waxed fat by increasing their respective market share of lab test referrals from office-based physicians. This era is poised to end as growing numbers of office-based physicians begin to practice medicine within an a…
Former Lab CEO Explains Why He Filed Lawsuit
By Robert Michel | From the Volume XIX No. 3 – February 20, 2012 Issue
CEO SUMMARY: It may be the first time that a former public laboratory CEO has turned whistleblower. Andrew Baker, formerly Chairman and CEO of Unilab Corporation in the 1990s, filed a qui tam case in federal court last year that centers on the practice of lab companies offering private he…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized